Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma (RMC)

By |2021-10-19T07:58:09+00:0019 Oct 2021|Subtypes of RCC|

Renal medullary carcinoma (RMC) is an extremely rare and aggressive [...]